Interleukin-10 at the crossroads of immunity in TLR7-induced lupus - Top-Institutions - MDSpire

Interleukin-10 at the crossroads of immunity in TLR7-induced lupus

  • By

  • Johanna Pauline Williams

  • Anaïs Amend

  • Anna-Lena Schäfer

  • Paola Fernanda Ruiz-Aparicio

  • Antoine Nicolas Kraemer

  • Aileen Qian Luo

  • Laura Riechert

  • Lara Weber

  • Baerbel Keller

  • Rudolf Armin Manz

  • Reinhard Edmund Voll

  • Nina Chevalier

  • June 22, 2026

  • 0 min

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    The Johns Hopkins Hospital / Johns Hopkins University School of Medicine
    The Johns Hopkins Hospital / Johns Hopkins University School of Medicine

    Baltimore, Maryland

    Key Differentiators

    • Immunology
    • Rheumatology

  • #2

    Brigham and Women’s Hospital (Harvard Medical School)
    Brigham and Women’s Hospital (Harvard Medical School)

    Boston, Massachusetts

    Key Differentiators

    • Immunology
    • Rheumatology

Original Source(s)

Interleukin-10 at the crossroads of immunity in TLR7-induced lupus

  • by Johanna Pauline Williams, Anaïs Amend, Anna-Lena Schäfer, Paola Fernanda Ruiz-Aparicio, Antoine Nicolas Kraemer, Aileen Qian Luo, Laura Riechert, Lara Weber, Baerbel Keller, Rudolf Armin Manz, Reinhard Edmund Voll, Nina Chevalier

  • June 22, 2026

Related Content

Systemic lupus erythematosus–driven accelerated atherosclerosis: the immune–metabolic–vascular axis and therapeutic implications

Correction: The association between systemic lupus erythematosus and cognitive impairment or dementia: a meta-analysis

FDA Clears Self-Administered Lupus Therapy

Once-weekly autoinjector approval was based on Phase 3 data, with safety consistent with intravenous administration.